{"transactions":[{"id":709981,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30608,"kind":"person","name":"Redfield Robert","position":1,"cik":"0002018274","reported_name":"Redfield Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-15T00:23:52.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":84000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options awarded by the Issuer's compensation committee (comprised of independent directors) to the reporting person under the Issuer's 2021 Incentive Compensation Plan, as amended and/or restated through the date hereof. The stock options under this award will vest 100% on the first anniversary of the grant date."}],"balance_after":84000,"derivative":{"exercise_price":0.68,"exercise_date":"2027-07-09","expiration_date":"2036-07-09","underlying":"Common Stock","underlying_shares":84000},"source":{"system":"sec-edgar","filing":"0002018274-26-000003","document":"form4-07152026_120748.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000201827426000003/form4-07152026_120748.xml","form_type":"4"}},{"id":851702,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30608,"kind":"person","name":"Redfield Robert","position":1,"cik":"0002018274","reported_name":"Redfield Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-10T23:15:00.000Z","date":"2026-03-08","kind":"grant","planned":false,"acquired":true,"shares":108854,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options awarded by the Issuer's compensation committee (comprised of independent directors) to the reporting person under the Issuer's 2021 Incentive Compensation Plan, as amended and/or restated through the date hereof.  The stock options under this award will vest 100% on the first anniversary of the grant date."}],"balance_after":108854,"derivative":{"exercise_price":1.6,"exercise_date":"2027-03-08","expiration_date":"2036-03-08","underlying":"Common Stock","underlying_shares":108854},"source":{"system":"sec-edgar","filing":"0002018274-26-000002","document":"form4-03102026_110357.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000201827426000002/form4-03102026_110357.xml","form_type":"4"}},{"id":968020,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30608,"kind":"person","name":"Redfield Robert","position":1,"cik":"0002018274","reported_name":"Redfield Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to purchase)","published_at":"2025-12-16T23:15:29.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":65676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest 100% on the first anniversary of the grant date."}],"balance_after":65676,"derivative":{"exercise_price":2.33,"exercise_date":"2026-12-12","expiration_date":"2035-12-12","underlying":"Common Stock","underlying_shares":65676},"source":{"system":"sec-edgar","filing":"0002018274-25-000004","document":"form4-12162025_111226.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000201827425000004/form4-12162025_111226.xml","form_type":"4"}},{"id":968019,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30608,"kind":"person","name":"Redfield Robert","position":1,"cik":"0002018274","reported_name":"Redfield Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-16T23:15:29.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":16419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units that will vest 100% on the first anniversary of the grant date. Each restricted stock unit will convert into shares of common stock on a one-for-one basis."}],"balance_after":113919,"source":{"system":"sec-edgar","filing":"0002018274-25-000004","document":"form4-12162025_111226.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000201827425000004/form4-12162025_111226.xml","form_type":"4"}},{"id":1018777,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30608,"kind":"person","name":"Redfield Robert","position":1,"cik":"0002018274","reported_name":"Redfield Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to purchase)","published_at":"2025-10-16T00:09:39.000Z","date":"2025-10-12","kind":"grant","planned":false,"acquired":true,"shares":32406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the first anniversary of the grant date."}],"balance_after":32406,"derivative":{"exercise_price":3.01,"exercise_date":"2026-10-12","expiration_date":"2035-10-12","underlying":"Common Stock","underlying_shares":32406},"source":{"system":"sec-edgar","filing":"0002018274-25-000003","document":"form4-10162025_121036.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000201827425000003/form4-10162025_121036.xml","form_type":"4"}},{"id":1550722,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30608,"kind":"person","name":"Redfield Robert","position":1,"cik":"0002018274","reported_name":"Redfield Robert","relationship":{"officer":true,"officer_title":"Acting Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-04-04T00:07:09.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":97500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units that will vest in four equal annual installments beginning April 1, 2025.  Each restricted stock unit will convert into common stock of Traws Pharma, Inc. (f/k/a Onconova Therapeutics, Inc.), par value $0.01 per share, on a one-for-one basis."}],"balance_after":97500,"source":{"system":"sec-edgar","filing":"0000929638-24-001366","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000092963824001366/form4.xml","form_type":"4"}}]}